WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s FARXIGA ® (dapagliflozin) has been approved by the US Food and Drug Administration (FDA) to improve glycemic control in pediatric patients with type-2 ...

Treatment with dapagliflozin led to a statistically significant improvement in HbA1c compared with placebo. The Food and Drug Administration (FDA) has expanded the approval of Farxiga ® (dapagliflozin ...

AstraZeneca AZN announced that the FDA granted label expansion to its blockbuster drug Farxiga (dapagliflozin) to treat pediatric patients aged 10 years and older with type-2 diabetes (T2D). Farxiga ...

Farxiga is a prescription oral tablet used to manage type 2 diabetes or certain heart or kidney conditions. It’s a brand-name drug with the active ingredient dapagliflozin. Farxiga tablets come in ...

Farxiga (dapagliflozin) is a prescription, brand-name medication. The Food and Drug Administration (FDA) has approved Farxiga for uses in certain adults. These uses include: Farxiga comes as an oral ...

Farxiga (dapagliflozin) is a prescription drug for treating type 2 diabetes, among other uses. Farxiga can cause side effects that range from mild to serious. Examples include genital-related side ...

Astrazeneca plc followed up its win a year ago in heart failure (HF) with yet another approval for its oral SGLT2 inhibitor, Farxiga (dapagliflozin), now cleared by the FDA to reduce the odds of ...

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) presented key data on the use of FARXIGA ® (dapagliflozin) in diverse patient populations with type 2 and type 1 diabetes (T2D, T1D) at the ...

LONDON, Aug 27 (Reuters) - AstraZeneca's (AZN.L), opens new tab blockbuster diabetes drug Farxiga led to significant reductions in the risk of hospitalisation and death in people with all types of ...

Dear Dr. Roach: My question is: What is the difference between prediabetes and diabetes, and which do I have? I am male, 85 years old, 170 pounds, and 6 feet and 1 inch tall. I was treated for heart ...